乳腺癌浸润性导管癌，免疫组化结果：ER（
2020-07-08 02:35发布
吴安乐
乳腺癌浸润性导管癌，免疫组化结果：ER（约90%+++），FR约20%+，HER-2（2+）这个严重吗
最多设置5个标签!
{var%20f='http://v.t.sina.com.cn/share/share.php?appkey=1515056452',u=z||d.location,p=['&url=',e(u),'&title=',e(t||d.title),'&source=',e(r),'&sourceUrl=',e(l),'&content=',c||'gb2312','&pic=',e(p||'')].join('');function%20a(){if(!window.open([f,p].join(''),'mb',['toolbar=0,status=0,resizable=1,width=440,height=430,left=',(s.width-440)/2,',top=',(s.height-430)/2].join('')))u.href=[f,p].join('');};if(/Firefox/.test(navigator.userAgent))setTimeout(a,0);else%20a();})(screen,document,encodeURIComponent,'','','https://www.otcfood.com/data/attach/logo/logo.png', '推荐 吴安乐 的问题《乳腺癌浸润性导管癌，免疫组化结果：ER（》','https://www.otcfood.com/answer/2390/3724.html','页面编码gb2312|utf-8默认gb2312'));){kind=link}
一周热门 更多>